Inventor
VALTON JULIEN
US20 patents
⚠️ This page may combine multiple inventors who share the name “VALTON JULIEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLECTIS
15 patentsUS10239948B2Mar 26, 2019
Method of engineering multi-input signal sensitive T cell for immunotherapy
CELLECTIS16 citations84
US11014989B2May 25, 2021
Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy
CELLECTIS2 citations73
US11186824B2Nov 30, 2021
Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
CELLECTIS4 citations72
US11220683B2Jan 11, 2022
Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains
CELLECTIS0 citations62
US10526406B2Jan 7, 2020
Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish
CELLECTIS1 citations62
US12391933B2Aug 19, 2025
Targeted gene insertion for improved immune cells therapy
CELLECTIS0 citations61
US12209125B2Jan 28, 2025
Targeted gene integration of NK inhibitors genes for improved immune cells therapy
CELLECTIS0 citations61
US11873511B2Jan 16, 2024
Targeted gene insertion for improved immune cells therapy
CELLECTIS0 citations61
US11136566B2Oct 5, 2021
Tale-protein scaffolds and uses thereof
CELLECTIS0 citations60
US11903968B2Feb 20, 2024
Engineered immune cells resistant to tumor microenvironment
CELLECTIS0 citations59
US11198856B2Dec 14, 2021
Method for the generation of compact tale-nucleases and uses thereof
CELLECTIS0 citations59
US12221478B2Feb 11, 2025
Targeted gene integration of CRS inhibitor genes for improved immune cells therapy
CELLECTIS0 citations58
US10894093B2Jan 19, 2021
Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation
CELLECTIS0 citations52
US10813951B2Oct 27, 2020
Method of engineering chemotherapy drug resistant T-cells for immunotherapy
CELLECTIS0 citations50
US10472396B2Nov 12, 2019
Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
CELLECTIS0 citations48
PFIZER
3 patentsUS10294304B2May 21, 2019
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER16 citations93
US11312782B2Apr 26, 2022
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER1 citations71
US11912776B2Feb 27, 2024
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER0 citations61